# Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-069
- **Status:** posted
- **Opens:** November 18, 2024
- **Closes:** January 7, 2027
- **CFDA:** 93.393
- **View on Kontrakk:** https://kontrakk.com/grants/357202

## Description

No description provided.